510(k) K212558
K212558 is an FDA 510(k) premarket notification submitted by Eclipse Medcorp, LLC for the device "MicroPen EVO". The FDA issued a decision of Substantially Equivalent on November 24, 2021. The device falls under product code QAI (Powered Microneedle Device), a Class II device regulated under 21 CFR 878.4430. Eclipse Medcorp, LLC has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 24, 2021
- Date Received
- August 13, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Powered Microneedle Device
- Device Class
- Class II
- Regulation Number
- 878.4430
- Review Panel
- SU
- Submission Type
A powered microneedle device is a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use.